2-(4-Methyl-2-methylamino-thiazol-5-yl)-3-o-tolyl-3H-quinazolin-4-one

ID: ALA515276

Chembl Id: CHEMBL515276

PubChem CID: 42631933

Max Phase: Preclinical

Molecular Formula: C20H18N4OS

Molecular Weight: 362.46

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CNc1nc(C)c(-c2nc3ccccc3c(=O)n2-c2ccccc2C)s1

Standard InChI:  InChI=1S/C20H18N4OS/c1-12-8-4-7-11-16(12)24-18(17-13(2)22-20(21-3)26-17)23-15-10-6-5-9-14(15)19(24)25/h4-11H,1-3H3,(H,21,22)

Standard InChI Key:  CNOZEZOCALUISD-UHFFFAOYSA-N

Associated Targets(Human)

JUN Tchem Proto-oncogene c-JUN (434 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFKB2 Tchem Nuclear factor NF-kappa-B complex (2307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 362.46Molecular Weight (Monoisotopic): 362.1201AlogP: 4.17#Rotatable Bonds: 3
Polar Surface Area: 59.81Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.64CX LogP: 4.10CX LogD: 4.10
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.59Np Likeness Score: -1.24

References

1. Giri RS, Thaker HM, Giordano T, Williams J, Rogers D, Sudersanam V, Vasu KK..  (2009)  Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-kappaB and AP-1 mediated transcription activation and as potential anti-inflammatory agents.,  44  (5): [PMID:19064304] [10.1016/j.ejmech.2008.10.031]
2. Ye N, Ding Y, Wild C, Shen Q, Zhou J..  (2014)  Small molecule inhibitors targeting activator protein 1 (AP-1).,  57  (16): [PMID:24831826] [10.1021/jm5004733]

Source